United States v. Arthrex, Inc., 141 S. Ct. 1970 (2021)
Perhaps unexpectedly, a case on the constitutionality of the Patent Trial and Appeal Board has major significance to the pressing policy crisis of drug prices in the United States. Erroneously issued patents monopolize medical therapies, making them unaffordable or inaccessible to numerous Americans. The inter partes review proceedings that the Board conducts have repeatedly and successfully overcome such patents, enabling competition and dramatically lowering prices. This Court should ensure the continued viability of the Board and of inter partes review, by preserving the Board’s objectivity and independence from executive branch political influence.
Duan, Charles, "Brief for the Coalition Against Patent Abuse as Amicus Curiae in Support No Party" (2020). Amicus Briefs. 31.